398 filings
Page 6 of 20
144
o02j x7d5phn1
5 Jun 23
Notice of proposed sale of securities
8:52pm
4
0l3ikioauffbotan5kb
5 Jun 23
Cerevel Therapeutics / Susan ALTSCHULLER ownership change
8:15pm
4
359ww3k 0v
5 Jun 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
8:12pm
4
ek4nj
5 Jun 23
Cerevel Therapeutics / Mark Bodenrader ownership change
8:07pm
144
fnh2cin8 jety5t
1 Jun 23
Notice of proposed sale of securities
4:19pm
3
5yrlh060zq120
19 May 23
Cerevel Therapeutics / Susan ALTSCHULLER ownership change
4:15pm
10-K/A
liyddr0 q8vd9hhq
19 May 23
Annual report (amended)
4:01pm
8-K
v84rvjl9p s8c
10 May 23
Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer
6:54am
144/A
apt00h4 ndzwrr2w
8 May 23
Notice of proposed sale of securities (amended)
7:03pm
144
a75g8bi375k3j1q
8 May 23
Notice of proposed sale of securities
4:40pm
4
k4q1i4t2y ravquo3pt
8 May 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:24pm
144
743dsrw86o
5 May 23
Notice of proposed sale of securities
3:15pm
144
5j2a6h
4 May 23
Notice of proposed sale of securities
2:50pm
144
oqt6h3 3n
4 May 23
Notice of proposed sale of securities
12:00am
8-K
7524nw5js8y4fy5eh4
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am
ARS
on60k4
28 Apr 23
Annual report to shareholders
4:35pm
DEFA14A
bfxitype8
28 Apr 23
Additional proxy soliciting materials
4:20pm
SC 13D/A
2zf195w g74
25 Apr 23
Cerevel Therapeutics / PERCEPTIVE ADVISORS ownership change
12:00am